Seo, Dong-Wan <br/><br/>
TIMP-2 disrupts FGF-2-induced downstream signaling pathways.  [electronic resource] 

 -  Microvascular research  Nov 2008 
 - 145-51 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1095-9319 
<br/><br/><label>Standard No.: </label>10.1016/j.mvr.2008.07.003  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Base Sequence<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Cells, Cultured<br/>Endothelial Cells--cytology<br/>Fibroblast Growth Factor 2--pharmacology<br/>Humans<br/>Integrin alpha3beta1--antagonists & inhibitors<br/>MAP Kinase Signaling System--drug effects<br/>Matrix Metalloproteinases--physiology<br/>Mitogen-Activated Protein Kinase 1--antagonists & inhibitors<br/>Mitogen-Activated Protein Kinase 3--antagonists & inhibitors<br/>Neovascularization, Physiologic<br/>Protein Tyrosine Phosphatase, Non-Receptor Type 6--physiology<br/>RNA, Small Interfering--genetics<br/>Receptor, Fibroblast Growth Factor, Type 1--physiology<br/>Recombinant Proteins--pharmacology<br/>Signal Transduction--drug effects<br/>Tissue Inhibitor of Metalloproteinase-2--pharmacology